NEW YORK, May 14 – Aptus Genomics added $6.2 million to its coffers in its latest round of financing, the Rockville, Maryland-based company announced Monday.
The funding came from Emerging Technology Partners, The Grosvenor Funds, and VitalBio.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.